FDA Issues CRL for Oxylanthanum Carbonate - Poll - MDSpire

FDA Issues CRL for Oxylanthanum Carbonate

The action relates to previously identified third-party manufacturing deficiencies rather than concerns about the clinical efficacy or safety data, according to the company.

  • By

  • Kathryn Wighton

  • June 30, 2026

  • 2 min

Share

Original Source(s)

FDA Issues CRL for Oxylanthanum Carbonate

  • by Kathryn Wighton

  • June 30, 2026

Related Content

Top 10 States with the Lowest Costs for Running a Medical Practice

These 10 states posted some of the lowest 2026 Medicare practice expense GPCI among states that CMS treats as a single statewide locality, with broader price levels and selected malpractice or tax indicators adding context.

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.

Mild Hyponatremia After TJA: Safe to Discharge?

Associations with medical and overall complications were largely driven by acute kidney injury in a retrospective single-center study